Skip to content

Screening Cardiovascular Patients for Aortic aNeurysms (SCAN)

Screening Cardiovascular Patients for Aortic aNeurysms (SCAN)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02179801
Acronym
SCAN
Enrollment
1000
Registered
2014-07-02
Start date
2014-03-31
Completion date
2018-04-30
Last updated
2017-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AAA, Abdominal Aortic Aneurysm

Keywords

Abdominal aortic aneurysm, AAA, Screening

Brief summary

The aim of the cohort study SCAN (Screening Cardiovascular patients for Aortic aNeurysms) is to establish a screening programm for patients with a high risk for an AAA. Aortic aneurysms in these patients should be identified at an early stage and thereby AAA-associated mortality be decreased.

Detailed description

A recently published meta-analysis showed a higher prevalence of aortic aneurysm (AAA) in men requiring treatment of coronary heart disaese compared to standard population. In women, however, the prevalence was not increased. Thus, the SCAN project addresses male patients who underwent coronary artery intervention in order to screen them for the presence of an AAA using duplex sonography. The SCAN project involves the following elements: 1. Informing the patient with cardiovascular risk factors about the clinical picture of AAA 2. An ultrasound scan of the abdominal aorta in patients with an increased risk for AAA 3. Acquisition of patient data followed by a correlation analysis for the parameters presence of AAA and cardiovascular diseases The cohort study is part of the SCAN project which is also conducted in an similar way by Catharina Ziekenhuis Eindhoven ClinicalTrials.gov Identifier:NCT01643317.

Interventions

None listed

Sponsors

I. Medizinischen Klinik und Poliklinik, Technical University of Munich
CollaboratorUNKNOWN
Technical University of Munich
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Healthy volunteers
No

Inclusion criteria

* men with coronary artery intervention (PTCA/stenting) * at least 1 risk factor for AAA (hypertension, hyperlipidaemia, hyperuricemia, nicotine abuse,positive family history)

Exclusion criteria

* life expectancy less than 1 year * inability to follow the instructions of the investigator (dementia, lack of time, insufficient understanding of the language) * insufficient compliance

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of AAA1 yearUltrasound screen for the presence of an AAA

Secondary

MeasureTime frameDescription
Prevalence of AAA in the cohort requiring treatment1 yearMeasuring the AAA diameter
Correlation of risk factors for AAA with risk factors for coronary artery disease1 yearTherefore the cardiovascular risk factors ( diabetes, hypertension, hyperlipidaemia, hyperuricemia, nicotine abuse, positive family history, obesity) will be requested.
Distribution of risk factors1 yearDistribution of cardiovascular risk factors (diabetes, hypertension, hyperlipidaemia, hyperuricemia, nicotine abuse, positive family history, obesity) between patients with an without an AAA
Correlation of the number of treated vessels and AAA1 year

Countries

Germany

Contacts

Primary ContactHans-Henning Eckstein, Univ.-Prof.Dr.med.
gefaesschirurgie@lrz.tum.de0049894140
Backup ContactBenedikt Reutersberg, Dr. med.
gefaesschirurgie@lrz.tum.de0049894140

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026